| |
| |
|
| Insider
Information: |
Logan Carolyn J |
| Relationship: |
President & CEO, Direc... |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
703,838 |
|
|
Indirect Shares
|
400,000 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,103,838 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
President & CEO, Direc... |
2014-12-22 |
703,838 |
2014-12-22 |
400,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
59 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2003-12-23 |
4 |
OE |
$1.70 |
$34,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2004-03-02 |
4 |
OE |
$1.70 |
$34,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2004-03-03 |
4/A |
OE |
$1.70 |
$34,000 |
D/D |
20,000 |
20,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2004-10-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,450 |
179,450 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2005-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,370 |
178,080 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2006-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,500 |
267,030 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2006-03-09 |
4 |
OE |
$1.13 |
$33,900 |
D/D |
30,000 |
297,030 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2006-05-09 |
4 |
B |
$13.23 |
$99,239 |
D/D |
7,500 |
304,530 |
2.81 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2006-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
69,750 |
374,280 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
71,540 |
445,820 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-07-03 |
4 |
AS |
$12.29 |
$70,251 |
D/D |
(5,710) |
440,110 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-07-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,000 |
470,110 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-07-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
1,000 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-07-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
468,110 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2007-11-16 |
4 |
B |
$10.48 |
$73,360 |
D/D |
7,000 |
475,110 |
2.81 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
98,200 |
561,847 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2008-07-01 |
4 |
D |
$7.03 |
$80,585 |
D/D |
(11,463) |
463,647 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2008-08-28 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,400 |
2,700 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2008-08-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,400 |
558,447 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
94,220 |
630,581 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-07-01 |
4 |
D |
$9.87 |
$217,989 |
D/D |
(22,086) |
536,361 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-09-14 |
4 |
AS |
$20.67 |
$206,742 |
D/D |
(10,000) |
630,581 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-09-14 |
4 |
OE |
$1.13 |
$11,300 |
D/D |
10,000 |
640,581 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-12-10 |
4 |
OE |
$1.13 |
$39,550 |
D/D |
35,000 |
665,581 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
President & CEO |
• • – |
2009-12-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,100 |
3,250 |
0 |
- |
|
59 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
